Advances in Heterocyclic Chemistry
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
Key Metrics
Journal Specifications
Indexed in the following public directories
Scopus 
Web of Science
- PublisherElsevier
- LanguageEnglish
- FrequencyTri-annual
- LanguageEnglish
- FrequencyTri-annual
- Publication Start Year1963
- Publisher URL
Topics Covered
Year-wise Publication
- 5Y
- 10Y
FAQs
Since when has Advances in Heterocyclic Chemistry been publishing? 
The Advances in Heterocyclic Chemistry has been publishing since 1963 till date.
How frequently is the Advances in Heterocyclic Chemistry published?
Advances in Heterocyclic Chemistry is published Tri-annual.
Who is the publisher of Advances in Heterocyclic Chemistry?
The publisher of Advances in Heterocyclic Chemistry is Elsevier.
How can I view the journal metrics of Advances in Heterocyclic Chemistry on editage?
For the Advances in Heterocyclic Chemistry metrics, please refer to the section above on the page.
What is the eISSN and pISSN number of Advances in Heterocyclic Chemistry?
The eISSN number is 1557-8429 and pISSN number is 0065-2725 for Advances in Heterocyclic Chemistry.
What is the focus of this journal?
The journal covers a wide range of topics inlcuding Diketene, Azole, Energy materials, Drug design, Drug discovery.
Why is it important to find the right journal for my research?
Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.
Can the choice of journal affect my academic career?
Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.
Is it advisable to target high-impact journals only?
While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.